Reducing Inflammation May Lower Dementia Risk in RA
Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.
The document provides an overview of guidelines on cardiovascular medicine that is intended to help clinicians in primary care manage their patients.
A study based on patients seen at an academic medical center reinforces the need for greater attention to gout during primary care visits.
Two studies provide new evidence and new angles for research into determining the origins of rheumatoid arthritis and potential ways to prevent or treat the disease early.
Research suggests a link between cardiometabolic comorbidities and obesity and gout in women, with genetic traits seen playing a lesser role.